Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AEBPE001.1
- Development stage
- Unknown
- Lead developer
- Ambiotech
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
ExoGiov (AEBPE001.1) is an exosome-based therapy developed by AM Biotech (Ascension Medical Biotechnology) using their proprietary Bio-Pulsed Activation Technique platform. This platform produces functionally induced exosomes—nanosized extracellular vesicles—that facilitate intercellular communication and deliver growth factors and anti-inflammatory agents to promote tissue repair and immune regulation. The product is marketed for aesthetic applications such as skincare and hair growth, where it has received approval, and is being investigated in preclinical stages for a variety of medical conditions including macular degeneration, retinal disease, dry eye, special trauma recovery, post-cancer treatment recovery, and chronic renal failure. The exosomes are characterized by high purity (up to 99.99%) and stability at room temperature.
- Brand names
- ExoGiov
Beyond the preview
Go deeper on AEBPE001.1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AEBPE001.1.